Response Genetics Inc - ESG Rating & Company Profile powered by AI
The Sustainability score for Response Genetics Inc represents the company's reporting of the UN SDGs. Full ESG analysis of Response Genetics Inc are accessed by registering for free. The assessment of Response Genetics Inc is assembled by All Street Sevva using proprietary Cognitive Robots.
Response Genetics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Response Genetics Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Response Genetics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Response Genetics Inc disclose current and historical energy intensity?
Does Response Genetics Inc report the average age of the workforce?
Does Response Genetics Inc reference operational or capital allocation in relation to climate change?
Does Response Genetics Inc disclose its ethnicity pay gap?
Does Response Genetics Inc disclose cybersecurity risks?
Does Response Genetics Inc offer flexible work?
Does Response Genetics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Response Genetics Inc disclose the number of employees in R&D functions?
Does Response Genetics Inc conduct supply chain audits?
Does Response Genetics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Response Genetics Inc conduct 360 degree staff reviews?
Does Response Genetics Inc disclose the individual responsible for D&I?
Does Response Genetics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Response Genetics Inc disclose current and / or historical scope 2 emissions?
Does Response Genetics Inc disclose water use targets?
Does Response Genetics Inc have careers partnerships with academic institutions?
Did Response Genetics Inc have a product recall in the last two years?
Does Response Genetics Inc disclose incidents of discrimination?
Does Response Genetics Inc allow for Work Councils/Collective Agreements to be formed?
Has Response Genetics Inc issued a profit warning in the past 24 months?
Does Response Genetics Inc disclose parental leave metrics?
Does Response Genetics Inc disclose climate scenario or pathway analysis?
Does Response Genetics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Response Genetics Inc disclose the pay ratio of women to men?
Does Response Genetics Inc support suppliers with sustainability related research and development?
Does Response Genetics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Response Genetics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Response Genetics Inc involved in embryonic stem cell research?
Does Response Genetics Inc disclose GHG and Air Emissions intensity?
Does Response Genetics Inc disclose its waste policy?
Does Response Genetics Inc report according to TCFD requirements?
Does Response Genetics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Response Genetics Inc disclose energy use targets?
Does Response Genetics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Response Genetics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Response Genetics Inc
These potential risks are based on the size, segment and geographies of the company.
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.